Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Noseda

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Advances in Experimental Medicine and Biology|April 11, 2020
Roneparstat: Development, Preclinical and Clinical StudiesAlessandro Noseda, Paola Barbieri
Matrix Biology : Journal of the International Society for Matrix Biology|March 27, 2016
Chemotherapy induces expression and release of heparanase leading to changes associated with an aggressive tumor phenotypeVishnu C Ramani, Israel Vlodavsky, Mary Ng, et al.
Oncotarget|December 2, 2015
Targeting heparanase overcomes chemoresistance and diminishes relapse in myelomaVishnu C Ramani, Fenghuang Zhan, Jianbo He, et al.
Scientific Reports|April 8, 2017
The Role of Heparanase in the Pathogenesis of Acute Pancreatitis: A Potential Therapeutic TargetIyad Khamaysi, Preeti Singh, Susan Nasser, et al.
Journal of Virology|March 23, 2022
Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19Jingyu Xiang, Mijia Lu, Min Shi, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Advances in Experimental Medicine and Biology|April 11, 2020
Roneparstat: Development, Preclinical and Clinical StudiesAlessandro Noseda, Paola Barbieri
Matrix Biology : Journal of the International Society for Matrix Biology|March 27, 2016
Chemotherapy induces expression and release of heparanase leading to changes associated with an aggressive tumor phenotypeVishnu C Ramani, Israel Vlodavsky, Mary Ng, et al.
Oncotarget|December 2, 2015
Targeting heparanase overcomes chemoresistance and diminishes relapse in myelomaVishnu C Ramani, Fenghuang Zhan, Jianbo He, et al.
Scientific Reports|April 8, 2017
The Role of Heparanase in the Pathogenesis of Acute Pancreatitis: A Potential Therapeutic TargetIyad Khamaysi, Preeti Singh, Susan Nasser, et al.
Journal of Virology|March 23, 2022
Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19Jingyu Xiang, Mijia Lu, Min Shi, et al.
Pageof 1